In conclusion, these findings underline the need for genetic screening of family members and the regular surveillance in patients with Alagille syndrome associated with JAG1/NOTCH2 variants, including subjects with or without mild liver involvement. This evidence concerns the gene JAG1 and Alagille syndrome.